Low-Level Laser Therapy for Plantar Fasciitis

N/A

Waitlist Available

Research Sponsored by The Geneva Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month

Summary

This trial aims to evaluate a new therapy to reduce pain and disability from foot injury in service members. Results will help inform best practices for treating foot-related issues.

Who is the study for?

Active-duty military members with a healthcare provider's diagnosis of Plantar Fasciitis, experiencing foot pain for at least 3 months, and able to commit to a 6-week treatment plus follow-ups. Excludes pregnant individuals, those on light/heat-sensitive meds or pacemakers, prior invasive treatments for the condition, significant tattoos/scarring on calves, neuropathy sufferers, and participants in other pain studies.

What is being tested?

The trial is testing Photobiomodulation Therapy (PBMT) against Sham-PBMT to see if PBMT can improve foot function and reduce pain more effectively. Up to 100 service members will be randomly assigned to either group and monitored over time for changes in foot function, pain levels, and plantar fascial thickness.

What are the potential side effects?

While specific side effects are not listed for PBMT or Sham-PBMT in this summary, potential risks may include skin warming due to light absorption which could lead to overheating of the skin especially where there is tattoo ink or scarring.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Baseline Data Collection CRF

Baseline Data Collection CRF (Fitzpatrick Skin Phototype)

Demographic Information

+3 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: The Usual Care + PBM GroupActive Control1 Intervention

Participants that are assigned to this group will receive active treatment with PBM 3 times a week for 3 weeks for a total of 9 treatments.

Group II: The Usual Care + Sham (Placebo) PBM GroupPlacebo Group1 Intervention

Participants that are assigned to this group will receive Sham PBM therapy 3 times a week for 3 weeks for a total of 9 treatments. Sham PBM therapy is an inactive harmless treatment that is intended to mimic the active PBM treatment.

Do I qualify?Apply below to find out